Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Adamas Pharma (NQ: ADMS )

8.220 USD UNCHANGED
Last Price Updated: 4:02 PM EST, Nov 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 8.220
Bid (Size) 8.230 (2)
Ask (Size) 8.490 (1)
Prev. Close 8.220
Today's Range 8.220 - 8.220
52wk Range 4.020 - 9.150
Shares Outstanding 45,595,824
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates UMPQ, XLRN, ADMS, AZPN; Shareholders are Encouraged to Contact the Firm
From ACCESSWIRE
Adamas Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Adamas Pharmaceuticals, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ADMS
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) to Supernus Pharmaceuticals, Inc. for $8.10 per share in cash plus... 
From Business Wire News Releases

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
+1.86%
+1.86%
6 Month
+71.25%
+71.25%
1 Year
+61.81%
+61.81%

More News

Read More
ADMS Crosses Above Average Analyst Target
Tags ETFs
From ETF Channel
Adamas Announces New Employment Inducement Grants
From Business Wire News Releases
Why Supernus' Acquisition of Adamas Is a Smart Move
Tags ADMS Market News SUPN
From Motley Fool
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Tags Commodities Penny Stocks CENX
From Benzinga
Adamas Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards
From Business Wire News Releases
12 Health Care Stocks Moving In Monday's Intraday Session
Tags VYGR Markets ADMS
From Benzinga
Mid-Day Market Update: Crude Oil Surges Over 2%; Supernus Pharmaceuticals To Acquire Adamas Pharmaceuticals
Tags Small Cap VYGR Markets
From Benzinga
ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. -
From Business Wire News Releases
Mid-Afternoon Market Update: Dow Tumbles Over 100 Points; Flexion Therapeutics Shares Spike Higher
Tags Stocks / Equities Market News
From TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.